Intrexon reported $41.73M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Arrowhead Research ARWR:US $ 86.41M 5.18M
AstraZeneca AZN:LN 6329M 738M
Bluebird Bio BLUE:US $ 396.62M 5.84M
Immunogen IMGN:US $ 437.66M 41.09M
Intrexon XON:US $ 41.73M 5.32M
Novartis NOVN:VX SF 12407M 5196M
Peregrine Pharmaceuticals PPHM:US $ 163.68M 3.98M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Xencor XNCR:US $ 78.27M 65.21M
Ziopharm Oncology ZIOP:US $ 68.26M 7.8M